A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
Status:
Completed
Trial end date:
2020-07-28
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of
tocilizumab (TCZ) compared with a matching placebo in combination with standard of care (SOC)
in hospitalized patients with severe COVID-19 pneumonia.